Reports - Sepsis Diagnostics Market
HealthcareSepsis Diagnostics Market
Sepsis Diagnostics Market Size Analysis Report 2025-2035 by Technologies (Blood Culture, Immunoassays, Molecular Diagnostics, Flow Cytometry, Microfluidics, Biomarkers) by Products (Blood Culture Media, Assays & Reagents, Instruments, Software) by Methods (Automated Diagnostics, Conventional Diagnostics) by Pathogens (Bacterial Sepsis, Fungal Sepsis, Viral Sepsis, Other Pathogens) by Test Types (Laboratory Tests, Point-of-Care Tests) by End Users (Hospitals & Specialty Clinics, Pathology & Reference Laboratories, Research Laboratories & Academic Institutes) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
Table of Contents
Chapter 1 Executive Dashboard
1. Strategic Imperatives
Chapter 2 Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Chapter 3 Global Sepsis Diagnostics Market - Segment Analysis
1. Overview
2. Global Sepsis Diagnostics Market, 2021 - 2035 (USD Million)
3. Global Sepsis Diagnostics Market - by Technologies
3.1. By Blood Culture
3.2. By Immunoassays
3.3. By Molecular Diagnostics
3.4. By Flow Cytometry
3.5. By Microfluidics
3.6. By Biomarkers
4. Global Sepsis Diagnostics Market - by Products
4.1. By Blood Culture Media
4.2. By Assays & Reagents
4.3. By Instruments
4.4. By Software
5. Global Sepsis Diagnostics Market - by Methods
5.1. By Automated Diagnostics
5.2. By Conventional Diagnostics
6. Global Sepsis Diagnostics Market - by Pathogens
6.1. By Bacterial Sepsis
6.2. By Fungal Sepsis
6.3. By Viral Sepsis
6.4. By Other Pathogens
7. Global Sepsis Diagnostics Market - by Test Types
7.1. By Laboratory Tests
7.2. By Point-of-Care Tests
8. Global Sepsis Diagnostics Market - by End Users
8.1. By Hospitals & Specialty Clinics
8.2. By Pathology & Reference Laboratories
8.3. By Research Laboratories & Academic Institutes
9. Global Sepsis Diagnostics Market - by region
9.1. North America
9.2. Europe
9.3. Asia Pacific
9.4. Latin America
9.5. Middle East & Africa
10. Market comparative analysis
Chapter 4 North America Sepsis Diagnostics Market - Segment Analysis
1. Overview
2. North America Sepsis Diagnostics Market, 2021 - 2035 (USD Million)
3. North America Sepsis Diagnostics Market - by Technologies
3.1. By Blood Culture
3.2. By Immunoassays
3.3. By Molecular Diagnostics
3.4. By Flow Cytometry
3.5. By Microfluidics
3.6. By Biomarkers
4. North America Sepsis Diagnostics Market - by Products
4.1. By Blood Culture Media
4.2. By Assays & Reagents
4.3. By Instruments
4.4. By Software
5. North America Sepsis Diagnostics Market - by Methods
5.1. By Automated Diagnostics
5.2. By Conventional Diagnostics
6. North America Sepsis Diagnostics Market - by Pathogens
6.1. By Bacterial Sepsis
6.2. By Fungal Sepsis
6.3. By Viral Sepsis
6.4. By Other Pathogens
7. North America Sepsis Diagnostics Market - by Test Types
7.1. By Laboratory Tests
7.2. By Point-of-Care Tests
8. North America Sepsis Diagnostics Market - by End Users
8.1. By Hospitals & Specialty Clinics
8.2. By Pathology & Reference Laboratories
8.3. By Research Laboratories & Academic Institutes
Chapter 5 Europe Sepsis Diagnostics Market - Segment Analysis
1. Overview
2. Europe Sepsis Diagnostics Market, 2021 - 2035 (USD Million)
3. Europe Sepsis Diagnostics Market - by Technologies
3.1. By Blood Culture
3.2. By Immunoassays
3.3. By Molecular Diagnostics
3.4. By Flow Cytometry
3.5. By Microfluidics
3.6. By Biomarkers
4. Europe Sepsis Diagnostics Market - by Products
4.1. By Blood Culture Media
4.2. By Assays & Reagents
4.3. By Instruments
4.4. By Software
5. Europe Sepsis Diagnostics Market - by Methods
5.1. By Automated Diagnostics
5.2. By Conventional Diagnostics
6. Europe Sepsis Diagnostics Market - by Pathogens
6.1. By Bacterial Sepsis
6.2. By Fungal Sepsis
6.3. By Viral Sepsis
6.4. By Other Pathogens
7. Europe Sepsis Diagnostics Market - by Test Types
7.1. By Laboratory Tests
7.2. By Point-of-Care Tests
8. Europe Sepsis Diagnostics Market - by End Users
8.1. By Hospitals & Specialty Clinics
8.2. By Pathology & Reference Laboratories
8.3. By Research Laboratories & Academic Institutes
Chapter 6 Asia Pacific Sepsis Diagnostics Market - Segment Analysis
1. Overview
2. Asia Pacific Sepsis Diagnostics Market, 2021 - 2035 (USD Million)
3. Asia Pacific Sepsis Diagnostics Market - by Technologies
3.1. By Blood Culture
3.2. By Immunoassays
3.3. By Molecular Diagnostics
3.4. By Flow Cytometry
3.5. By Microfluidics
3.6. By Biomarkers
4. Asia Pacific Sepsis Diagnostics Market - by Products
4.1. By Blood Culture Media
4.2. By Assays & Reagents
4.3. By Instruments
4.4. By Software
5. Asia Pacific Sepsis Diagnostics Market - by Methods
5.1. By Automated Diagnostics
5.2. By Conventional Diagnostics
6. Asia Pacific Sepsis Diagnostics Market - by Pathogens
6.1. By Bacterial Sepsis
6.2. By Fungal Sepsis
6.3. By Viral Sepsis
6.4. By Other Pathogens
7. Asia Pacific Sepsis Diagnostics Market - by Test Types
7.1. By Laboratory Tests
7.2. By Point-of-Care Tests
8. Asia Pacific Sepsis Diagnostics Market - by End Users
8.1. By Hospitals & Specialty Clinics
8.2. By Pathology & Reference Laboratories
8.3. By Research Laboratories & Academic Institutes
Chapter 7 Latin America Sepsis Diagnostics Market - Segment Analysis
1. Overview
2. Latin America Sepsis Diagnostics Market, 2021 - 2035 (USD Million)
3. Latin America Sepsis Diagnostics Market - by Technologies
3.1. By Blood Culture
3.2. By Immunoassays
3.3. By Molecular Diagnostics
3.4. By Flow Cytometry
3.5. By Microfluidics
3.6. By Biomarkers
4. Latin America Sepsis Diagnostics Market - by Products
4.1. By Blood Culture Media
4.2. By Assays & Reagents
4.3. By Instruments
4.4. By Software
5. Latin America Sepsis Diagnostics Market - by Methods
5.1. By Automated Diagnostics
5.2. By Conventional Diagnostics
6. Latin America Sepsis Diagnostics Market - by Pathogens
6.1. By Bacterial Sepsis
6.2. By Fungal Sepsis
6.3. By Viral Sepsis
6.4. By Other Pathogens
7. Latin America Sepsis Diagnostics Market - by Test Types
7.1. By Laboratory Tests
7.2. By Point-of-Care Tests
8. Latin America Sepsis Diagnostics Market - by End Users
8.1. By Hospitals & Specialty Clinics
8.2. By Pathology & Reference Laboratories
8.3. By Research Laboratories & Academic Institutes
Chapter 8 Middle East & Africa Sepsis Diagnostics Market - Segment Analysis
1. Overview
2. Middle East & Africa Sepsis Diagnostics Market, 2021 - 2035 (USD Million)
3. Middle East & Africa Sepsis Diagnostics Market - by Technologies
3.1. By Blood Culture
3.2. By Immunoassays
3.3. By Molecular Diagnostics
3.4. By Flow Cytometry
3.5. By Microfluidics
3.6. By Biomarkers
4. Middle East & Africa Sepsis Diagnostics Market - by Products
4.1. By Blood Culture Media
4.2. By Assays & Reagents
4.3. By Instruments
4.4. By Software
5. Middle East & Africa Sepsis Diagnostics Market - by Methods
5.1. By Automated Diagnostics
5.2. By Conventional Diagnostics
6. Middle East & Africa Sepsis Diagnostics Market - by Pathogens
6.1. By Bacterial Sepsis
6.2. By Fungal Sepsis
6.3. By Viral Sepsis
6.4. By Other Pathogens
7. Middle East & Africa Sepsis Diagnostics Market - by Test Types
7.1. By Laboratory Tests
7.2. By Point-of-Care Tests
8. Middle East & Africa Sepsis Diagnostics Market - by End Users
8.1. By Hospitals & Specialty Clinics
8.2. By Pathology & Reference Laboratories
8.3. By Research Laboratories & Academic Institutes
Chapter 9 Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
Chapter 10 COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Chapter 11 Marketing Strategy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Chapter 12 Competitive Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Chapter 13 Company Profiles
1. bioMérieux SA (France)
2. Becton
3. Dickinson & Company (U.S.)
4. Pfizer Inc. (U.S.)
5. Thermo Fisher Scientific Inc. (U.S.)
6. GlaxoSmithKline PLC (U.K.)
7. F. Hoffmann-La Roche Ltd (Switzerland)
8. Beckman Coulter Inc. (U.S.)
9. Luminex Corp. (U.S.)
10. Amara Health Analytics (U.S.)
11. Mckesson Corp. (U.S.)
12. AbbVie Inc. (Allergan Pharmaceuticals International Limited) (U.S.)
Chapter 14 Key Primary Respondents - VERBATIM
Chapter 15 Discussion Guide
Chapter 16 Customization Offered
Chapter 17 Annexure
Chapter 18 List of Figures
Chapter 19 List of Tables
Chapter 20 List of Abbreviations
FAQ‘s
Related Reports
Contact
Toll Free Number+1 (877) 462-2282
© 2025 Vantage Market Research. All right reserved
Secured By